Tnfrsf17 - tumor necrosis factor receptor superfamily, member 17 Gene

Also Known as BCM; BCMA; Tnfrsf13; Tnfrsf13a

Species: Mus musculus

Gene Type: protein coding
Gene ID: 21935

Summary

Predicted to enable signaling receptor activity. Acts upstream of or within lymphocyte homeostasis. Predicted to be located in membrane. Predicted to be integral component of membrane. Is expressed in ileum; male reproductive gland or organ; superior cervical ganglion; thymus; and urinary system. Human ortholog(s) of this gene implicated in colon carcinoma and multiple myeloma. Orthologous to human TNFRSF17 (TNF Receptor Superfamily member 17). [provided by Alliance of Genome Resources, Apr 2022]

Tnfrsf17 Products (1)

mRNA Protein Name
NM_011608.1 NP_035738.1 tumor necrosis factor receptor superfamily member 17

Gene Ontology

  • Biological Process
Biological Process GO Annotation Evidence References Source
acts upstream of or within lymphocyte homeostasis IMP
IMP: Inferred from mutant phenotype
14707116 MGI
EXP: Inferred from Experiment IDA: Inferred from direct assay IPI: Inferred from physical interaction IMP: Inferred from mutant phenotype IGI: Inferred from genetic interaction IEP: Inferred from expression pattern
Protein Preferred Names Protein Names

tumor necrosis factor receptor superfamily member 17

  • B-cell maturation protein

Recombinant Tnfrsf17 Proteins

Cat. No. Product Name Accession Purity
HY-P7656 BCMA/TNFRSF17 Protein, Mouse (HEK293, Fc) O88472-1 (M1-T49) ≥ 95%, as determined by reducing SDS-PAGE.
HY-P72849 BCMA/TNFRSF17 Protein, Mouse (Biotinylated, HEK293, Fc-Avi) O88472-1 (M1-T49) ≥ 90%, as determined by reducing SDS-PAGE.
HY-P72850 BCMA/TNFRSF17 Protein, Mouse (HEK293, His-Fc) O88472-1 (M1-T49) ≥ 90%, as determined by reducing SDS-PAGE.
HY-P78072 BCMA/TNFRSF17 Protein, Mouse (Biotinylated, HEK293, His-Avi) O88472-1 (M1-T49) ≥ 95%, as determined by Bis-Tris PAGE.
HY-P78243 BCMA/TNFRSF17 Protein, Mouse (HEK293, His-Avi) O88472-1 (M1-T49) ≥ 95%, as determined by Bis-Tris PAGE.

Related Agents

  • Approval
  • Clinical Phase
  • Pre-clinical Phase

Approval

Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Rare Diseases
HY-P99909 Elranatamab 98.74% Unkown

Clinical Phase

Inhibitory Antibodies (1)
Cat. No. Product Name Effect
Purity Phase
HY-P9980 Belantamab Inhibitor 99.90% Phase 3

Pre-clinical Phase

Bioactive Molecules (4)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-185002 BCMA CAR mRNA / Unkown
HY-RS14807 TNFRSF17 Human Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS16981 Tnfrsf17 Mouse Pre-designed siRNA Set A Pre-designed Set / Unkown
HY-RS23424 Tnfrsf17 Rat Pre-designed siRNA Set A Pre-designed Set / Unkown
Inhibitory Antibodies (9)
Cat. No. Product Name
Effect
Purity
Rare Diseases
HY-P991155 Ramantamig Inhibitor 95% Unkown
HY-P9980A Belantamab (FUT8-KO) 98.10% Unkown
HY-P990686 Ispectamab 98.102% Unkown
HY-P991686 Gamgertamig Inhibitor 99.32% Unkown
HY-P991014 Pamlectabart Inhibitor 97.00% Unkown
HY-P990939 Podentamig Inhibitor 98.35% Unkown
HY-P992136 Torutamig Inhibitor / Unkown
HY-P991003 Ingitamig Inhibitor / Unkown
HY-P991878 TBL-CLN1 / Unkown

Orthologs Information

Species Symbol Source ID
Homo sapiens Tnfrsf17 NCBI NCBI:608